Meta-regression of randomized control trials with antithrombotics: weak correlation between net clinical benefit and all cause-mortality

This study aimed to explore the validity of the use of the net clinical benefit (NCB), i.e. the sum of major bleeding and thrombotic events, as a potential surrogate for all-cause mortality in clinical trials assessing antithrombotics. Published randomized controlled trials testing anticoagulants in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kilo, Roubi, Laporte, Silvy, Arab, Rama, Mainbourg, Sabine, Provencher, Steeve, Grenet, Guillaume, Bertoletti, Laurent, Villeneuve, Laurent, Cucherat, Michel, Lega, Jean-Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290002/
https://www.ncbi.nlm.nih.gov/pubmed/34282198
http://dx.doi.org/10.1038/s41598-021-94160-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290002/
https://www.ncbi.nlm.nih.gov/pubmed/34282198
http://dx.doi.org/10.1038/s41598-021-94160-1

Ejemplares similares